These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1961 related articles for article (PubMed ID: 30995507)

  • 1. Transforming Growth Factor-β Signaling in Immunity and Cancer.
    Batlle E; Massagué J
    Immunity; 2019 Apr; 50(4):924-940. PubMed ID: 30995507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ in T cell biology and tumor immunity: Angel or devil?
    Tu E; Chia PZ; Chen W
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):423-35. PubMed ID: 25156420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta: a master switch in tumor immunity.
    Gigante M; Gesualdo L; Ranieri E
    Curr Pharm Des; 2012; 18(27):4126-34. PubMed ID: 22630082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
    Harper J; Sainson RC
    Semin Cancer Biol; 2014 Apr; 25():69-77. PubMed ID: 24406209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases.
    Sheng J; Chen W; Zhu HJ
    Growth Factors; 2015 Apr; 33(2):92-101. PubMed ID: 25714613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta regulation of immune responses.
    Li MO; Wan YY; Sanjabi S; Robertson AK; Flavell RA
    Annu Rev Immunol; 2006; 24():99-146. PubMed ID: 16551245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β activation and function in immunity.
    Travis MA; Sheppard D
    Annu Rev Immunol; 2014; 32():51-82. PubMed ID: 24313777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy.
    Zhao H; Wei J; Sun J
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107101. PubMed ID: 33099067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor -beta receptor signaling in cancer.
    Narayan S; Thangasamy T; Balusu R
    Front Biosci; 2005 May; 10():1135-45. PubMed ID: 15769612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the regulatory roles of the TGF-β family of cytokines.
    Fujio K; Komai T; Inoue M; Morita K; Okamura T; Yamamoto K
    Autoimmun Rev; 2016 Sep; 15(9):917-22. PubMed ID: 27392504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression.
    van den Bulk J; de Miranda NFCC; Ten Dijke P
    Clin Sci (Lond); 2021 Jan; 135(1):35-52. PubMed ID: 33399850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polarization of immune cells in the tumour environment by TGFbeta.
    Flavell RA; Sanjabi S; Wrzesinski SH; Licona-Limón P
    Nat Rev Immunol; 2010 Aug; 10(8):554-67. PubMed ID: 20616810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β signalling and its role in cancer progression and metastasis.
    Drabsch Y; ten Dijke P
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):553-68. PubMed ID: 22714591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta: receptors, signaling pathways and autoimmunity.
    Chen W; Wahl SM
    Curr Dir Autoimmun; 2002; 5():62-91. PubMed ID: 11826761
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells.
    Takasaka N; Seed RI; Cormier A; Bondesson AJ; Lou J; Elattma A; Ito S; Yanagisawa H; Hashimoto M; Ma R; Levine MD; Publicover J; Potts R; Jespersen JM; Campbell MG; Conrad F; Marks JD; Cheng Y; Baron JL; Nishimura SL
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
    Pardali K; Moustakas A
    Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of TGF-β signaling: a potential target for cancer immunotherapy?
    Ungefroren H
    Expert Opin Ther Targets; 2019 Aug; 23(8):679-693. PubMed ID: 31232607
    [No Abstract]   [Full Text] [Related]  

  • 18. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives.
    Dituri F; Mancarella S; Cigliano A; Chieti A; Giannelli G
    Semin Liver Dis; 2019 Feb; 39(1):53-69. PubMed ID: 30586675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta knockout and dominant-negative receptor transgenic mice.
    Letterio JJ; Böttinger EP
    Miner Electrolyte Metab; 1998; 24(2-3):161-7. PubMed ID: 9525700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 99.